ABIONYX PHARMA |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.146 EUR | -0.35% |
|
-1.72% | -36.40% |
| 06-14 | Abionyx: positive response from FDA, share price rises | CF |
| 06-13 | ABIONYX Pharma Completes Pre-IND Meeting with the FDA for CER-001 Phase 2b/3 Clinical Trial for Patients with Sepsis | CI |
- Stock Market
- Equities
- ABNX Stock
- 609 Stock
- News ABIONYX Pharma
- Analyst Reco.
